Corline Biomedical Balance Sheet Health
Financial Health criteria checks 5/6
Corline Biomedical has a total shareholder equity of SEK93.3M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK100.1M and SEK6.8M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr17.01m |
| Equity | kr93.32m |
| Total liabilities | kr6.79m |
| Total assets | kr100.11m |
Recent financial health updates
We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth
Mar 15
We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow
Nov 26Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business
Jun 22We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth
Feb 16Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth
Jun 14Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation
Feb 28Recent updates
We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth
Mar 15We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow
Nov 26Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business
Jun 22We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth
Feb 16Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth
Jun 14Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation
Feb 28Financial Position Analysis
Short Term Liabilities: CLBIO's short term assets (SEK23.8M) exceed its short term liabilities (SEK6.8M).
Long Term Liabilities: CLBIO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CLBIO is debt free.
Reducing Debt: CLBIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CLBIO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CLBIO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.6% each year